DURAPREP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Duraprep, and what generic alternatives are available?
Duraprep is a drug marketed by 3M and is included in one NDA.
The generic ingredient in DURAPREP is iodine povacrylex; isopropyl alcohol. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iodine povacrylex; isopropyl alcohol profile page.
Summary for DURAPREP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 9 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DURAPREP at DailyMed |
Recent Clinical Trials for DURAPREP
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, San Diego | Phase 4 |
| McMaster University | Phase 4 |
| University of Maryland | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for DURAPREP
US Patents and Regulatory Information for DURAPREP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m | DURAPREP | iodine povacrylex; isopropyl alcohol | SPONGE;TOPICAL | 021586-001 | Sep 29, 2006 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| 3m | DURAPREP | iodine povacrylex; isopropyl alcohol | SPONGE;TOPICAL | 021586-002 | Sep 29, 2006 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
